These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27773596)

  • 21. Improving Laboratory Efficiency in the Caribbean to Attain the World Health Organization HIV Treat All Recommendations.
    Alemnji G; Chase M; Branch S; Guevara G; Nkengasong J; Albalak R
    AIDS Res Hum Retroviruses; 2018 Feb; 34(2):132-139. PubMed ID: 28967269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral load detection using dried blood spots in a cohort of HIV-1-infected children in Uganda: correlations with clinical and immunological criteria for treatment failure.
    Costenaro P; Lundin R; Petrara MR; Penazzato M; Massavon W; Kizito S; Nabachwa SM; Nannyonga Musoke M; Namisi C; Morelli E; Bilardi D; Mazza A; Zanchetta M; Giaquinto C; De Rossi A
    J Clin Microbiol; 2014 Jul; 52(7):2665-7. PubMed ID: 24789197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study.
    Lesosky M; Glass T; Mukonda E; Hsiao NY; Abrams EJ; Myer L
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and evaluation of an affordable real-time qualitative assay for determining HIV-1 virological failure in plasma and dried blood spots.
    Aitken SC; Kliphuis A; Bronze M; Wallis CL; Kityo C; Balinda S; Stevens W; Spieker N; de Oliveira T; Rinke de Wit TF; Schuurman R
    J Clin Microbiol; 2013 Jun; 51(6):1899-905. PubMed ID: 23596235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation and operational feasibility of SAMBA I HIV-1 semi-quantitative viral load testing at the point-of-care in rural settings in Malawi and Uganda.
    Gueguen M; Nicholas S; Poulet E; Schramm B; Szumilin E; Wolters L; Wapling J; Ajule E; Rakesh A; Mwenda R; Kiyaga C; Balkan S
    Trop Med Int Health; 2021 Feb; 26(2):184-194. PubMed ID: 33159822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scale-up of HIV Viral Load Monitoring--Seven Sub-Saharan African Countries.
    Lecher S; Ellenberger D; Kim AA; Fonjungo PN; Agolory S; Borget MY; Broyles L; Carmona S; Chipungu G; De Cock KM; Deyde V; Downer M; Gupta S; Kaplan JE; Kiyaga C; Knight N; MacLeod W; Makumbi B; Muttai H; Mwangi C; Mwangi JW; Mwasekaga M; Ng'Ang'A LW; Pillay Y; Sarr A; Sawadogo S; Singer D; Stevens W; Toure CA; Nkengasong J
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1287-90. PubMed ID: 26605986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
    Kumarasamy N; Krishnan S
    Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Optimizing resources to reduce costs to determine HIV viral load in limited resources settings].
    Girón-Callejas A; Mendizabal-Burastero R; Yax E; Martínez A; Mejía-Villatoro C
    Biomedica; 2017 Dec; 37(4):460-465. PubMed ID: 29373766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of highly active antiretroviral therapy in HIV infection.
    Walker AS; Gibb DM
    Curr Opin Infect Dis; 2011 Feb; 24(1):27-33. PubMed ID: 21150591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 viral load testing in resource-limited settings: Challenges and solutions for specimen integrity.
    Newman H; Hardie D
    Rev Med Virol; 2021 Mar; 31(2):e2165. PubMed ID: 32978882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developments in CD4 and viral load monitoring in resource-limited settings.
    Rowley CF
    Clin Infect Dis; 2014 Feb; 58(3):407-12. PubMed ID: 24218101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Very early virological failure and drug resistance mutations in a woman on antiretroviral therapy in Eastern Cape, South Africa: a case report.
    Sogbanmu OO; Adeniyi OV; Fuentes YO; Ter Goon D
    J Med Case Rep; 2015 May; 9():106. PubMed ID: 25947544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a prequalification panel for rapid scale-up of high-throughput HIV viral load testing.
    Scott LE; Carmona S; Gous N; Horsfield P; Mackay M; Stevens W
    J Clin Microbiol; 2012 Dec; 50(12):4083-6. PubMed ID: 22993182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings.
    Rutstein SE; Golin CE; Wheeler SB; Kamwendo D; Hosseinipour MC; Weinberger M; Miller WC; Biddle AK; Soko A; Mkandawire M; Mwenda R; Sarr A; Gupta S; Mataya R
    AIDS Care; 2016; 28(1):1-10. PubMed ID: 26278724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of routine viral load monitoring in low- and middle-income countries: a systematic review.
    Barnabas RV; Revill P; Tan N; Phillips A
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests.
    Garrido C; Zahonero N; Corral A; Arredondo M; Soriano V; de Mendoza C
    J Clin Microbiol; 2009 Apr; 47(4):1031-6. PubMed ID: 19193847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
    Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
    J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4 count-based failure criteria combined with viral load monitoring may trigger worse switch decisions than viral load monitoring alone.
    Hoffmann CJ; Maritz J; van Zyl GU
    Trop Med Int Health; 2016 Feb; 21(2):219-23. PubMed ID: 26584666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.
    Oliveira R; Krauss M; Essama-Bibi S; Hofer C; Robert Harris D; Tiraboschi A; de Souza R; Marques H; Succi R; Abreu T; Della Negra M; Hazra R; Mofenson LM; Siberry GK;
    Clin Infect Dis; 2010 Dec; 51(11):1325-33. PubMed ID: 21039218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.